Yirui Pharmaceutical Technology

Company Drug

Yirui Pharmaceutical’s YR001 Completes Successful Phase I Clinical Study in the US

Fineline Cube Oct 31, 2023

Hangzhou-based Yirui Pharmaceutical Technology Co., Ltd has announced the successful conclusion of a Phase I...

Company Deals Medical Device

Junion Therapeutics Secures RMB 100 Million Series A Financing for Weight Loss Device

Company Deals Drug

Eli Lilly Collaborates with BigHat Biosciences to Engineer Advanced Therapeutic Antibodies

Company Drug

Shanghai Henlius Initiates Phase II Study of HLX22 in HER2 Low Breast Cancer

Company Drug

GSK’s Blenrep Approved by UK MHRA for Multiple Myeloma Treatment